News

The EUnetHTA 21 2nd Open Call for applications from the pharmaceutical industry for Joint Scientific Consultations (JSCs) closed on 31 August, 2022. The EUnetHTA 21

EUnetHTA 21 announces that the public consultation for the draft deliverable D4.4 Endpoints is open until 1.11.2022, 23:59 CEST. The draft deliverable as well as

EUnetHTA 21 is pleased to announce the publication of the deliverable D4.2 Scoping Process. More information can be found here: https://www.eunethta.eu/d4-2/ Many thanks to all involved in

EUnetHTA 21 announces that the public consultation for four deliverables D4.3.1 Practical guideline on comparators and comparisons, D5.2 Guidance on JCA Assessment Report Template, D7.2

EUnetHTA 21 is pleased to announce the publication of three deliverables: D4.3.2 Methodological Guideline on direct and indirect comparisons; D4.7.1/2 Synthesis of national requirements /

EUnetHTA 21 announces that the public consultation for the deliverable D7.1 – Guidance on interaction between Health Technology Developer and HTA  is open until 19.08.2022,

EUnetHTA 21 announces that the public consultation for three deliverables D4.5 Applicability of Evidence; D4.6 Validity of clinical studies and D5.1 Guidance for JCA Submission

EUnetHTA 21 is pleased to announce the publication of the deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor. More information can be found

EUnetHTA 21 announces that the public consultation for D4.7.3/D4.7.4 (EUDAMED data reporting template / Guidance for EUDAMED-based TISP process) is open until 05.07.2022, 23:59 CET.

EUnetHTA 21 launches the second Open Call for applications from the pharmaceutical industry for five Joint Scientific Consultations (JSCs). The Open Call will remain open